Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms

Metastatic colorectal cancer (CRC) with a mismatch repair-deficiency (MMR-D)/microsatellite instability-high (MSI-H) phenotype carries unique characteristics such as increased tumour mutational burden and tumour-infiltrating lymphocytes. Studies have shown a sustained clinical response to immune che...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahin, Ibrahim Halil, Akce, Mehmet, Alese, Olatunji, Shaib, Walid, Lesinski, Gregory B., El-Rayes, Bassel, Wu, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889302/
https://www.ncbi.nlm.nih.gov/pubmed/31607751
http://dx.doi.org/10.1038/s41416-019-0599-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889302/
https://www.ncbi.nlm.nih.gov/pubmed/31607751
http://dx.doi.org/10.1038/s41416-019-0599-y

Ejemplares similares